Benefits
Selenomethionine bioavailability advantage
Vanderbilt PK study compared three selenium forms in 88 subjects across three doses (200, 400, 600 mcg). Selenomethionine showed ~60% absorption (measured by urinary excretion) vs ~41% for sodium selenite, with selenium yeast intermediate. Selenomethionine absorption is dose-dependent (more is absorbed at higher doses); inorganic selenite absorption plateaus.
Thyroid hormone metabolism support
Selenium is essential for iodothyronine deiodinase enzymes (D1, D2, D3) that convert thyroid hormone T4 to active T3. Selenium deficiency impairs T4→T3 conversion and can produce hypothyroid-like symptoms even with adequate iodine. Particularly relevant for autoimmune thyroid conditions (Hashimoto's) where selenium supplementation (200 mcg/day) has been shown to reduce TPO antibody levels in multiple trials.
Glutathione peroxidase antioxidant activity
Selenium is the active site of glutathione peroxidase enzymes (GPx1-GPx8), which reduce hydrogen peroxide and lipid peroxides — primary cellular antioxidant defense. Marginal selenium deficiency impairs GPx activity even when overt deficiency isn't present. Supplementing to optimal status (≥125 mcg/L plasma) maximizes GPx capacity.
Immune function support
Selenium is required for proper T-cell and NK-cell function, antibody production, and antiviral immunity. Studies in selenium-deficient populations (parts of China, New Zealand) show supplementation improves immune markers. Severe selenium deficiency in HIV/AIDS patients is associated with worse outcomes; supplementation has shown benefits in this population.
Food-form organic delivery
Yeast-bound selenomethionine is incorporated into food-protein-equivalent structures rather than being a free inorganic salt. This matches the form selenium takes in the diet (Brazil nuts, seafood, organ meats) and may offer better tolerability and absorption profile, especially for individuals with sensitive stomachs.
Tissue selenium accumulation
Selenomethionine accumulates in body proteins (because it can substitute for methionine in protein synthesis), creating a tissue reservoir of selenium. Inorganic selenite doesn't accumulate this way. This can be advantageous for maintaining selenium status during periods of low intake, but also means selenium status takes longer to reverse after stopping supplementation.
Mechanism of action
Selenoprotein synthesis
Selenium is incorporated as selenocysteine (Sec, the 21st amino acid) into approximately 25 human selenoproteins via the UGA-Sec recoding mechanism. These include the glutathione peroxidases, thioredoxin reductases, iodothyronine deiodinases, and selenoprotein P. Adequate selenium status is required for full expression of this entire protein family.
Antioxidant defense via glutathione peroxidase
Glutathione peroxidase (GPx) uses selenocysteine to catalytically reduce hydrogen peroxide and organic peroxides to water and alcohols, protecting cellular membranes and DNA from oxidative damage. Eight GPx isoforms target different cellular compartments and substrates.
Thyroid hormone activation
Type 1 (D1) and Type 2 (D2) deiodinases convert T4 to bioactive T3 — essential for cellular thyroid hormone signaling. Type 3 (D3) deactivates T4 to reverse T3. All three are selenoenzymes; selenium deficiency impairs the full T4-T3-rT3 equilibrium that regulates thyroid hormone action at tissue level.
Methylselenol formation (selenomethionine specific)
Selenomethionine is metabolized to methylselenol — a metabolite with preferential cancer-cell apoptosis activity. This metabolic pathway is more active with selenomethionine than with inorganic selenium forms, partially explaining preferential effects of organic selenium in cancer prevention research.
Clinical trials
Randomized controlled trial in 88 subjects comparing three selenium forms (selenomethionine, sodium selenite, high-selenium yeast) at three dose levels (200, 400, 600 mcg). 16-week supplementation. Outcome: selenomethionine absorbed ~60% based on urinary excretion vs ~41% for selenite; yeast intermediate. Selenomethionine absorption was dose-dependent (proportional increase with dose); selenite absorption plateaued at higher doses.
Multiple RCTs (Gärtner 2002, Mazokopakis 2007, others) and meta-analyses show 200 mcg/day organic selenium supplementation reduces thyroid peroxidase (TPO) antibody titers in patients with autoimmune thyroiditis. Effects emerge over 3-6 months. Symptomatic improvement variable; antibody reduction more consistent than symptomatic benefit.